Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9617884rdf:typepubmed:Citationlld:pubmed
pubmed-article:9617884lifeskim:mentionsumls-concept:C0175677lld:lifeskim
pubmed-article:9617884lifeskim:mentionsumls-concept:C0040300lld:lifeskim
pubmed-article:9617884lifeskim:mentionsumls-concept:C1331262lld:lifeskim
pubmed-article:9617884lifeskim:mentionsumls-concept:C0022116lld:lifeskim
pubmed-article:9617884lifeskim:mentionsumls-concept:C0086140lld:lifeskim
pubmed-article:9617884lifeskim:mentionsumls-concept:C0035124lld:lifeskim
pubmed-article:9617884lifeskim:mentionsumls-concept:C2699787lld:lifeskim
pubmed-article:9617884pubmed:issue5lld:pubmed
pubmed-article:9617884pubmed:dateCreated1998-7-31lld:pubmed
pubmed-article:9617884pubmed:abstractTextThe aim of this study was to evaluate the effect of dextran (Dx) 1 versus Dx 60 (molecular weights 1,000 and 60,000) on microvascular disturbances and tissue injury in striated muscle after ischemia/reperfusion (I/R). Experiments were performed using a 4 h pressure-induced ischemia model in the hamster dorsal skinfold chamber. Three groups (n=6) of animals received a continuous infusion (45 min, 3 microL/min) of either Dx 1 or Dx 60 (total dose 5 mg/kg) or saline solution beginning 15 min before reperfusion. Intravital fluorescence microscopy allowed for quantification of functional capillary density, leukocyte adherence, extravasation of fluorescein isothiocyanate-Dx, and nonviable (propidium-positive) cell count before ischemia and .5, 2, and 24 h after reperfusion. Experiments were terminated with tissue preservation for electron microscopy. Postischemic functional capillary density was significantly improved by Dx 60 (at 24 h, 88% vs. 51% in controls). In animals receiving postischemic Dx 1 or Dx 60, leukocyte adherence was significantly reduced (at .5 h, 44% and 58%, respectively) as compared with controls, whereas macromolecular extravasation was unchanged. Nonviable cell count was significantly decreased by both Dx fractions (at 24 h, Dx 1, 75%; Dx 60, 87%), indicating a reduction of tissue injury, which was also confirmed by electron microscopy. These results provide evidence that Dx 60 at 5 mg/kg attenuates I/R injury more effectively than Dx 1. Leukocytes play a major role in the development of I/R injury, but macromolecular extravasation does not always correlate with the leukocyte-endothelium interaction and the manifestation of I/R injury.lld:pubmed
pubmed-article:9617884pubmed:languageenglld:pubmed
pubmed-article:9617884pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9617884pubmed:citationSubsetIMlld:pubmed
pubmed-article:9617884pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9617884pubmed:statusMEDLINElld:pubmed
pubmed-article:9617884pubmed:monthMaylld:pubmed
pubmed-article:9617884pubmed:issn1073-2322lld:pubmed
pubmed-article:9617884pubmed:authorpubmed-author:MessmerKKlld:pubmed
pubmed-article:9617884pubmed:authorpubmed-author:HarrisA GAGlld:pubmed
pubmed-article:9617884pubmed:authorpubmed-author:LeidererRRlld:pubmed
pubmed-article:9617884pubmed:authorpubmed-author:AbelsCClld:pubmed
pubmed-article:9617884pubmed:authorpubmed-author:SteinbauerMMlld:pubmed
pubmed-article:9617884pubmed:issnTypePrintlld:pubmed
pubmed-article:9617884pubmed:volume9lld:pubmed
pubmed-article:9617884pubmed:ownerNLMlld:pubmed
pubmed-article:9617884pubmed:authorsCompleteYlld:pubmed
pubmed-article:9617884pubmed:pagination345-51lld:pubmed
pubmed-article:9617884pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:meshHeadingpubmed-meshheading:9617884-...lld:pubmed
pubmed-article:9617884pubmed:year1998lld:pubmed
pubmed-article:9617884pubmed:articleTitleImpact of dextran on microvascular disturbances and tissue injury following ischemia/reperfusion in striated muscle.lld:pubmed
pubmed-article:9617884pubmed:affiliationInstitute for Surgical Research, University of Munich, Germany.lld:pubmed
pubmed-article:9617884pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9617884pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed